Lori W. Wilson

507 total citations
15 papers, 391 citations indexed

About

Lori W. Wilson is a scholar working on Surgery, Molecular Biology and Internal Medicine. According to data from OpenAlex, Lori W. Wilson has authored 15 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Molecular Biology and 4 papers in Internal Medicine. Recurrent topics in Lori W. Wilson's work include Venous Thromboembolism Diagnosis and Management (4 papers), Heparin-Induced Thrombocytopenia and Thrombosis (3 papers) and Acute Myocardial Infarction Research (3 papers). Lori W. Wilson is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (4 papers), Heparin-Induced Thrombocytopenia and Thrombosis (3 papers) and Acute Myocardial Infarction Research (3 papers). Lori W. Wilson collaborates with scholars based in United States and Netherlands. Lori W. Wilson's co-authors include Anthony Lucci, Christopher M. Lehman, Lance A. Liotta, E Schiffmann, Mary L. Stracke, Jason D. Engel, Matthew M. Rechler, Pond R. Kelemen, George M. Rodgers and James T. Wu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and CHEST Journal.

In The Last Decade

Lori W. Wilson

15 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lori W. Wilson United States	9	123	106	98	85	68	15	391
Ayse Anil Timur United States	10	66 0.5×	180 1.7×	314 3.2×	47 0.6×	56 0.8×	16	585
Stavros N Georgiannos United Kingdom	10	70 0.6×	58 0.5×	78 0.8×	101 1.2×	184 2.7×	13	427
Rafał Małecki Poland	11	44 0.4×	64 0.6×	102 1.0×	24 0.3×	39 0.6×	34	308
Virtudes Vila Spain	13	90 0.7×	167 1.6×	55 0.6×	10 0.1×	88 1.3×	32	491
Edelmiro Regañón Spain	13	86 0.7×	159 1.5×	39 0.4×	10 0.1×	86 1.3×	25	427
Dìlek Dìnçol Türkiye	10	46 0.4×	73 0.7×	56 0.6×	79 0.9×	143 2.1×	28	394
Jean-Paul de Vries Netherlands	15	133 1.1×	124 1.2×	278 2.8×	11 0.1×	52 0.8×	31	719
Hong Jo Choi South Korea	12	100 0.8×	148 1.4×	177 1.8×	48 0.6×	276 4.1×	25	546
Roz Gibbs United Kingdom	7	108 0.9×	129 1.2×	83 0.8×	49 0.6×	123 1.8×	10	400

Countries citing papers authored by Lori W. Wilson

Since Specialization

Citations

This map shows the geographic impact of Lori W. Wilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori W. Wilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori W. Wilson more than expected).

Fields of papers citing papers by Lori W. Wilson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori W. Wilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori W. Wilson. The network helps show where Lori W. Wilson may publish in the future.

Co-authorship network of co-authors of Lori W. Wilson

This figure shows the co-authorship network connecting the top 25 collaborators of Lori W. Wilson. A scholar is included among the top collaborators of Lori W. Wilson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori W. Wilson. Lori W. Wilson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Wilson, Lori W., et al.. (2020). PCN69 COST-EFFECTIVENESS OF DARATUMUMAB ADDED TO LENALIDOMIDE AND DEXAMETHASONE FOR TRANSPLANT INELIGIBLE MULTIPLE MYELOMA. Value in Health. 23. S35–S35. 1 indexed citations

Niemeijer, Anna-Larissa N., Egbert F. Smit, Guus A.M.S. van Dongen, et al.. (2017). MA 05.07 Whole Body PD-1 and PD-L1 PET in Pts with NSCLC. Journal of Thoracic Oncology. 12(11). S1817–S1817. 1 indexed citations

Lehman, Christopher M., et al.. (2006). Comparative Performance of Three Anti-Factor Xa Heparin Assays in Patients in a Medical Intensive Care Unit Receiving Intravenous, Unfractionated Heparin. American Journal of Clinical Pathology. 126(3). 416–421. 1 indexed citations

Lehman, Christopher M., et al.. (2006). Comparative Performance of Three Anti–Factor Xa Heparin Assays in Patients in a Medical Intensive Care Unit Receiving Intravenous, Unfractionated Heparin. American Journal of Clinical Pathology. 126(3). 416–421. 26 indexed citations

Elkin, Eric P., Lori W. Wilson, Natalia Sadetsky, et al.. (2005). Long-term health care resource utilization in men with localized prostate cancer treated with radical prostatectomy: Data from CaPSURE. Journal of Clinical Oncology. 23(16_suppl). 6078–6078. 1 indexed citations

Markewitz, Boaz A., et al.. (2004). Concordance of the Activated Partial Thromboplastin Time and the Anti-Activated Factor X Assay in Monitoring Unfractionated Heparin Therapy in Critically Ill Patients. CHEST Journal. 126(4). 875S–875S. 1 indexed citations

Lehman, Christopher M., Lori W. Wilson, & Lori W. Wilson. (2004). Analytic Validation and Clinical Evaluation of the STA LIATEST Immunoturbidimetric D-Dimer Assay for the Diagnosis of Disseminated Intravascular Coagulation. American Journal of Clinical Pathology. 122(2). 178–184. 25 indexed citations

Lehman, Christopher M., Lori W. Wilson, & George M. Rodgers. (2004). Analytic Validation and Clinical Evaluation of the STA LIATEST Immunoturbidimetric D-Dimer Assay for the Diagnosis of Disseminated Intravascular Coagulation. American Journal of Clinical Pathology. 122(2). 178–184. 29 indexed citations

Lucci, Anthony, et al.. (2001). Assessment of Knowledge of Melanoma Risk Factors, Prevention, and Detection Principles in Texas Teenagers. Journal of Surgical Research. 97(2). 179–183. 30 indexed citations

10.

Lucci, Anthony, et al.. (2001). National Practice Patterns of Sentinel Lymph Node Dissection for Breast Carcinoma. Journal of the American College of Surgeons. 192(4). 453–458. 96 indexed citations

11.

Wu, James T., et al.. (1998). Development of an immunoassay specific for the PSA-ACT complex without the problem of high background. Journal of Clinical Laboratory Analysis. 12(1). 14–19. 21 indexed citations

12.

Wu, James T., Ping Zhang, Mark E. Astill, et al.. (1995). Psa immunoreactivity detected in lncap cell medium, breast tumor cytosol, and female serum. Journal of Clinical Laboratory Analysis. 9(4). 243–251. 11 indexed citations

13.

Stracke, Mary L., Jason D. Engel, Lori W. Wilson, et al.. (1989). The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells. Journal of Biological Chemistry. 264(36). 21544–21549. 135 indexed citations

14.

Wilson, Lori W., et al.. (1988). Progesterone receptor: stability studies and correlation between steroid binding assay and enzyme immunoassay.. Clinical Chemistry. 34(10). 1987–1991. 10 indexed citations

15.

Sternlieb, Irmin, et al.. (1954). Turner's syndrome associated with carcinoma of the rectosigmoid.. PubMed. 54(11). 1663–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact